Identifying and addressing the educational needs of patients from marginalized groups on less-than-ideal kidneys

Study Lead

Dr Marie-Chantal Fortin

University of Montreal (CR CHUM), University of Saskatchewan and University of British Columbia

Overview

Transplantation is a life-saving therapy for patients with kidney disease, but patients continue to deteriorate on the waitlist. Meanwhile, sometimes physicians decline deceased donor kidney offers on behalf of their patients without discussing it with them. The purpose of this study is to learn about how people feel about decision-making about deceased donor kidneys. We also want to learn what people know about how kidneys are allocated and how they feel about less-than-ideal kidneys. The purpose of this study is to explore the unique needs of patients and caregivers from minority groups and develop an educational toolkit in order to help patients with the decision-making process to accept or decline a kidney from a marginal donor.

Deadline to participate: 31/11/2025

Eligibility

You are eligible to participate in this study if you are a kidney transplant recipient, a candidate for a kidney transplant or a caregiver, and, you are from an Indigenous (First Nations, Métis, Inuit), or an historically marginalized community in Canada (such as Afro-Caribbean, South or East Asian, or African).

Type of Participation

Interview

Diagnosis

Chronic Kidney Disease

Treatment

Transplantation

Topic

Caregivers, Peer Support, Self-Management

Location

All provinces and territories

Related studies

  • Research Participation Through a Rural Lens: Facilitating Equitable Inclusion of Rural Voices

    Overview:

    Study type: Survey

    June 10, 2026

  • Nicotinamide chemoprevention for keratinocyte carcinoma in solid organ transplant recipients: a multi-centre, pragmatic randomized trial

    Overview:

    Study type: Clinical Trial

    May 22, 2026

  • Choosing Care That Fits: Integrating Frailty into Shared Decision Making for Advanced Kidney Disease

    Overview:

    Study type: Patient Partnership

    May 15, 2026